In this roundtable discussion with industry leaders, we’ll explore how teams are rethinking earnings workflow using AI, focusing on practical applications.
Join us to discover what has changed in AI-led drug development in the last year, which breakthroughs actually matter, and what to watch for in the year ahead.
In this roundtable, Doug Garber (Pitch The PM), Chris Vitale (the alloy network), and Ben Collins (AlphaSense) will discuss how AI is actually being deployed on the ground today — what’s working, what isn’t, and where the biggest ROI is emerging.